Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01MA12	LEVOFLOXACIN COOPER	G	Levofloxacin (hemihydrate) - 500mg/100ml	500mg/100ml	Injectable solution	959,504 L.L
L04AA06	IMUNOCELL	G	Mycophenolate mofetil - 500mg	500mg	Tablet, film coated	3,791,428 L.L
M01AE03	SOLKET INFLAMMATION AND PAIN	G	Ketoprofen Lysine salt - 0.16%	0.16%	Spray	946,065 L.L
N02AX02	TRAMADOL DENK 50	G	Tramadol HCl - 50mg	50mg	Tablet, effervescent	256,674 L.L
N06AB10	ESCITALOPRAM BIOGARAN	G	Escitalopram (oxalate) - 10mg	10mg	Tablet, coated, scored	678,640 L.L
R06AX27	DESLOR MEDIS	G	Desloratadine - 5mg	5mg	Tablet, film coated	396,434 L.L
A02BC01	OMEPRAL	G	Omeprazole - 10mg	10mg	Powder for suspension	890,776 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	193,062 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 50mg	50mg	Tablet, coated	1,744,308 L.L
C09CA04	GIZLAN	G	Irbesartan - 150mg	150mg	Tablet, film coated	748,520 L.L
C10AA05	TOVAST	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, film coated	2,412,197 L.L
D10AD01	AVOTIN-A	G	Tretinoin - 0.05%	0.05%	Cream	440,780 L.L
G04BE08	ENKOR	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,766,193 L.L
J01MA12	LEVOFLOXACIN- HAMELN	G	Levofloxacin - 500mg/100ml	5mg/ml	Injectable solution	1,632,769 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 5mg	5mg	Tablet	95,532,998 L.L
L04AA06	MMF	G	Mycophenolate mofetil - 500mg	500mg	Tablet, coated	4,087,969 L.L
N06AB10	ESCITALOPRAM NORMON	G	Escitalopram - 10mg	10mg	Tablet, film coated	845,277 L.L
R03AC02	ASMALAT	G	Salbutamol (sulfate) - 2mg/5ml	2mg/5ml	Syrup	177,899 L.L
R06AX27	ESLORAT	G	Desloratadine - 5mg	5mg	Tablet, film coated	331,929 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,104,639 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 50mg	50mg	Tablet, coated	1,744,308 L.L
C09CA04	IBECARD 150- IPS	G	Irbesartan - 150mg	150mg	Tablet, film coated	564,414 L.L
C10AA05	ATORVASTATINE ARROW GENERIQUES	G	Atorvastatin - 80mg	80mg	Tablet, coated	564,414 L.L
D10AD01	KETREL	G	Tretinoin - 0.05%	0.05%	Cream	397,777 L.L
G04BE08	HEROX	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,416,410 L.L
J01CR50	FLUMOX	G	Flucloxacillin (monohydrate) - 250mg, Amoxicillin (trihydrate) - 250mg		Capsule	348,055 L.L
J01MA12	LEVOFLOXACIN NORMON	G	Levofloxacin - 500mg/100ml	5mg/ml	Injectable solution	27,147,388 L.L
N06AB10	MEDIPREX	G	Escitalopram - 10mg	10mg	Tablet, film coated	456,906 L.L
R03AC02	BUTALIN	G	Salbutamol (sulfate) - 2mg/5ml	2mg/5ml	Syrup, sugar free	122,290 L.L